Trials / Completed
CompletedNCT06368986
A Study to Investigate the Effect of Food on the Bioavailability of a Capsid Inhibitor (CAI) in Male and Female Healthy Participants
An Open Label, Phase 1 Study to Assess the Effect of Food on Bioavailability for an Investigational Capsid Inhibitor in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate effect of food (in fasted and fed conditions) on the bioavailability of CAI VH4011499.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VH4011499 Dose A | VH4011499 administered in fasted or fed conditions. |
| DRUG | VH4011499 Dose B | VH4011499 Dose B administered in fasted or fed conditions. |
Timeline
- Start date
- 2024-04-17
- Primary completion
- 2024-10-02
- Completion
- 2024-10-02
- First posted
- 2024-04-16
- Last updated
- 2025-02-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06368986. Inclusion in this directory is not an endorsement.